There's medicine for COVID! (but it's a hassle)

Early November was full of ballot counting and news of successful vaccine trials.  With those stories dominating headlines, news of the Emergency Use Authorization of a new COVID-19 medicine went under the radar.   Remember Donald Trump getting the Regeneron monoclonal antibody early on?  That was one of two monoclonal antibody therapeutics formulated to fight COVID-19.  Dr. Daniel Griffin fills us in.

Please note: a more recent update to this story is available at